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ARTICLE OPEN
Adolescent seasonal allergic rhinitis and the impact of
health-care professional training: cluster randomised
controlled trial of a complex intervention in primary care
Victoria S Hammersley1, Rob A Elton1, Samantha Walker1, Christian H Hansen2 and Aziz Sheikh1,3
BACKGROUND: Seasonal allergic rhinitis is typically poorly managed, particularly in adolescents, in whom it is responsible for
considerable morbidity. Our previous work has demonstrated that if poorly controlled this can impair educational performance.
AIM: The primary aim of this trial was to assess the impact of a primary care–based professional training intervention on clinical
outcomes in adolescents with seasonal allergic rhinitis.
METHODS: Cluster trial in which UK general practice staff were randomised to a short, intensive workshop on the evidence-based
management of seasonal allergic rhinitis. The primary outcome measure was the change in the validated Rhinoconjunctivitis
Quality of Life Questionnaire with Standardized Activities (RQLQ(S)) score between baseline and 6 weeks post intervention (minimal
clinically important difference = 0.5). Secondary outcome measures of interest included health-care professionals’ knowledge and
conﬁdence in managing seasonal allergic rhinitis, number of seasonal allergic rhinitis-related consultations, relevant treatments
prescribed and symptom scores.
RESULTS: Thirty-eight general practices were randomised (20 in the intervention arm) and 246 patients (50.2% males, mean age 15
years) were included in the primary outcome analysis. Health-care professionals’ knowledge and conﬁdence of the clinical
management of seasonal allergic rhinitis improved. This did not, however, result in clinically or statistically signiﬁcant improvements
in RQLQ(S): − 0.15, (95% conﬁdence interval, − 0.5 to +0.2). There were no differences in consultation frequency, treatments issued
for seasonal allergic rhinitis or symptom scores.
CONCLUSIONS: Although associated with increases in professionals’ self-assessed conﬁdence and understanding of seasonal
allergic rhinitis management, this intensive training workshop did not translate into improvements in adolescents’ disease-speciﬁc
quality of life or a reduction in rhinitis symptoms.
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INTRODUCTION
Seasonal allergic rhinitis (also known as intermittent allergic
rhinitis) is a very common condition in adolescence, with national1
and international2–4 studies suggesting that up to 40% of young
people may be affected. It can be responsible for considerable
morbidity in its own right; research focusing on children and
adolescents with seasonal allergic rhinitis has identiﬁed particular
problems with schoolwork,5 exam performance6 as well as loss of
sleep and reduced ability to concentrate.7,8 As a consequence,
seasonal allergic rhinitis poses a substantial and increasing
economic burden on health-care systems and the society at
large.9 American estimates have, for example, suggested that
health-care expenditure associated with allergic rhinitis has
doubled since 2000, increasing to more than $11 billion.10 It is
now better recognised that many people with seasonal allergic
rhinitis also have coexistent asthma and this, together with a
greater appreciation of their shared pathophysiology, has led the
World Health Organization to promote the idea of ‘one airway,
one disease’—i.e., that allergic rhinitis and asthma are different
manifestations of the same disease.
Considerable time and resources are expended on educational
interventions for health-care professionals, both in the United
Kingdom and internationally, but despite these investments their
impact on patient outcomes is still unknown. This is because such
interventions are rarely evaluated beyond simple measures of
satisfaction completed by the attendee, with little or no
assessment of whether there is any impact on clinical practice
or beneﬁts to patients. Any intervention requiring time and/or
ﬁnancial commitment should be subject to the same rigorous
evaluation as any other pharmacological or non-pharmacological
intervention, and this is particularly true in ﬁnancially constrained
times. More speciﬁcally, the management of people with seasonal
allergic rhinitis (and allergic rhinitis more generally) has been
highlighted as being suboptimal by a number of studies11,12 and
guidelines,8 with these inadequacies resulting in substantial—
potentially avoidable—morbidity and cost. The overwhelming
majority of people with seasonal allergic rhinitis are managed in
the community;13 hence, this sector needs to be the focus of any
attempt to improve the quality of care and outcomes.2
In an earlier multicentre randomised controlled trial,14 it was
demonstrated that a part-time 6-month diploma-level allergy
course was acceptable to attending primary health-care profes-
sionals, led to changes in relevant process measures (such as
knowledge and conﬁdence) and, importantly, translated into
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signiﬁcant improvements in validated measures of disease-speciﬁc
quality of life in adults. Although effective, many primary health-
care professionals found this length of training difﬁcult to
incorporate into their practice, which raises important questions
about the wider generalisability and sustainability of this
approach. Following the approach advocated by the Medical
Research Council’s Framework for Complex Interventions,15,16 we
used our experiences from this earlier trial and related work on the
training needs of primary care professionals in the context of
managing seasonal allergic rhinitis to inform the development of
the current intervention.12,17,18 In seeking to mirror the ways in
which the majority of UK health-care professionals receive their
continuing professional education, we developed an intensive,
evidence-based 1-day educational training intervention for
primary care professionals. We then sought to evaluate the
effectiveness of this training intervention for primary care–based
health-care professionals on adolescent disease-speciﬁc quality
of life.
MATERIALS AND METHODS
Overview of study design
We conducted a cluster randomised controlled trial of an educational
intervention, which involved randomising general practice staff to receive
either evidence-based allergy training or to the control arm in which
practices received written guidance on the evidence-based management
of seasonal allergic rhinitis.19 We chose a cluster randomised controlled
trial, as a parallel group trial design would have resulted in a high risk of
contamination. In keeping with recommended practice, our trial protocol
and detailed analysis plan were reported before the closure of the trial;20
any deviations from the methods described in the protocol are
detailed below.
Setting and participants
This trial took place during the summers of 2009 and 2010 in 38 general
practices within the recruitment areas of the Scottish Primary Care
Research Network and England’s Northern and Yorkshire Research
Network. Scottish Primary Care Research Network and England’s Northern
and Yorkshire Research Network invited general practices to take part by
email and letter. Each consenting practice was asked to nominate a
member of their team to participate who had not received postgraduate
allergy training in the previous 12 months. All patients aged 12–18 years
with current seasonal allergic rhinitis were eligible to participate. We
deﬁned current seasonal allergic rhinitis by the presence of a documented
clinician diagnosis in the patient’s electronic health record and any
evidence of treatment(s) used for seasonal allergic rhinitis in the last 2
years.21 Patients who fulﬁlled these criteria were invited to take part in the
trial via a letter from the practice, which included a participant information
sheet, consent form and reply envelope for return directly to the
research team.
Randomisation and blinding
Practices were stratiﬁed on the basis of each of six regions: NHS Lothian;
NHS South of Tyne and Wear; NHS North of Tyne; NHS County Durham;
NHS North Yorkshire and York; and NHS Leeds; for regions where there
were more than two clusters, a centrally administered minimisation
scheme22 based on practice size and deprivation score was applied.
Patients were masked to the allocation; however, it was not possible to
mask the general practices as the intervention was attendance at a training
workshop.
Intervention
Education for Health (http://www.educationforhealth.org.uk/) is one of
UK’s leading independent national training organisations offering accre-
dited allergy training for professionals. We worked with Education for
Health to develop an intensive 1-day evidence-based workshop, which was
customised to meeting the needs of adolescents (see Box 1). The
intervention consisted of an intensive study day focused on the diagnosis
and management of young people with seasonal allergic rhinitis. The
programme began with an assessment of the participant’s current allergy
knowledge, followed by the presentation of a case study, a discussion
about the importance of getting the diagnosis of allergy correct and
reasons for treatment failure. This was then followed by a brief overview of
the pathophysiology of allergy in general, before moving into a more
detailed discussion of this in the context of seasonal allergic rhinitis and
asthma. Embedded within the programme were practical sessions on nasal
spray and inhaler device technique. Delegates were given a copy of the
British Society of Allergy & Clinical Immunology allergic rhinitis algorithm,19
and all treatment discussions were based on the World Health Organiza-
tion’s Allergic Rhinitis and Asthma23 and British Thoracic Society/Scottish
Intercollegiate Guidelines Network (http://www.sign.ac.uk/guidelines/full-
text/101/index.html) guidelines on the management of allergic rhinitis and
asthma, respectively (current at the time of the study). There was ample
time for individual and group discussions to ensure that individual learning
styles were catered for and any queries were addressed.
Health-care professionals (1 general practitioner and 19 practice nurses)
nominated by the general practices who were randomised to the
intervention arm attended these 1-day intensive workshops delivered by
experienced Education for Health trainers. The course was repeated on ﬁve
occasions.
Control group
Health-care professionals (again nominated by the practices and in this
case all nurses) in the control practices received an allergic rhinitis
algorithm developed by the British Society of Allergy & Clinical
Immunology,19 which was adapted for use in primary care by Education
for Health. No training was offered to the 18 health-care professionals
randomised to the control arm.
Objectives and outcomes
Our primary outcome of interest was the difference in the change in
adolescents Standardised Rhinoconjunctivitis Quality of Life Questionnaire
(RQLQ(S)) score between baseline and 6 weeks post intervention in the
intervention arm compared with the control arm. Consenting patients
completed the RQLQ(S) and a symptoms score, which was measured on a
10-point visual analogue scale. Data were collected from two cohorts of
patients in two separate years: 2009 and 2010. Baseline RQLQ(S) and
symptom scores were recorded in May and early June 2009/2010; patients
were then seen by their health-care professional, and follow-up RQLQ(S)
and symptom scores were recorded in late June and July 2009/2010 (i.e.,
during the peak of the grass pollen season).
Our secondary outcomes of interest were:
● Assessment of change in clinical practice among the health-care
professionals allocated to the intervention arm: the effects of the 1-day
training on self-reported professional conﬁdence, and understanding
and clinical management of seasonal allergic rhinitis, which were
measured immediately before and after the training days, and after all
the patients taking part in the study had been seen by a health-care
professional (~7–28 days), using a questionnaire that incorporated a 5-
point Likert scale (1 = less conﬁdent and 5=more conﬁdent).
● Total number of consultations for seasonal allergic rhinitis.
● Total number of prescribed medications for seasonal allergic rhinitis.
● Patient-reported symptom scores.
Pollen data
Grass pollen data from York and Edinburgh (which covered the areas from
which practices were drawn) were centrally provided by the National
Pollen and Aerobiology Research Unit for 2009 and 2010 in order to assess
whether the pollen counts reached a level that was likely to trigger
Box 1 Main topics covered in the seasonal allergic rhinitis
training workshop
● History taking
● Diagnosis
● Treatment and management of allergic airways
● Identiﬁcation and management of relevant co-morbidities
● Compliance and nasal spray device technique
● Organisational issues
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seasonal allergic rhinitis symptoms during the study period. The pollen
count is a measure of the number of pollen grains per cubic metre (pg/m3)
of air sampled, averaged over 24 h.
Sample size calculations
We calculated that a target sample size of 220 would give 80% power to
detect a mean difference of 0·5 in RQLQ(S) score—the minimal clinically
important difference at the 5% signiﬁcance level. This was calculated using
Sampsize24 assuming an s.d. of 1.225 and intraclass correlation (ICC) of 0.02.
There is little evidence in the literature of the likely size of the design effect
from clustering in trials of this kind, and the choice of the relatively low ICC
value of 0.02 was based mainly on the ﬁnding of no evidence of clustering
in our earlier adult study using RQLQ.14
Statistical analysis
We undertook a complete case analysis for our main analysis. In the
primary analysis, multilevel modelling using a random effects model was
used to take account of between- and within-cluster variation, adjusting
for strata, individual covariates and year of study. Estimates and conﬁdence
intervals of the intervention effects are reported for the RQLQ(S) and
symptom score.
Consultation and prescribing data were collected from the participating
general practices for all patients from the date of consultation for
the study to 31 August 2009/2010. Differences between the two
groups were analysed using multilevel analysis in MLWin (version
2.20, 2010, http://www.bristol.ac.uk/cmm/software/mlwin/).
Differences in the mean scores of self-reported conﬁdence and
understanding of seasonal allergic rhinitis management in the intervention
group were compared using t-statistics.
We ﬁrst used mixed-model analysis of variance (ANOVA) using SPSS (version
14, 2005, SPSS, Chicago, IL, USA) to estimate the ICC for RQLQ(S), followed by a
Bayesian approach using WinBUGS (version 1.4, 2009, http://www2.mrc-bsu.
cam.ac.uk/bugs/winbugs/contents.shtml), taking a uniform prior over 0–1.26
Deviations from the trial protocol
Educational data. We were unable to collect educational data
because of time constraints resulting from the delays in recruiting
practices.
Follow-up RQLQ(S). Follow-up primary outcome data were collected
by post and the majority were collected 6 weeks post intervention as
planned and described in the trial protocol;20 however, there were a small
number of questionnaires collected between 6 and 8 weeks post
intervention as a result of non-responders to the initial mailing and the
need to issue reminders.
Missing data. Our complete case analysis provided unbiased estimates
under the assumption that the missing data are ‘Missing Completely At
Random’;27 however, analysis of the means estimated separately for each
pattern of missingness suggested that this assumption may not hold. We
therefore carried out further sensitivity analyses testing a variety of
assumptions:
● The direct likelihood method:28 the primary analysis of the effect
of the intervention on RQLQ(S) was repeated, but with the baseline
score modelled jointly with the outcome at 6 weeks instead of entering
the model through the linear predictor. This model allowed for the
inclusion of all 309 patients with data on at least one occasion and
provided likelihood-based estimates that are valid under ‘Missing
At Random’27 (under the assumption that the responses are multivariate
normal).
● Multiple imputation: Proc MI in SAS (SAS Institute, Cary, NC, USA) was
used to generate multiple imputations separately for each treatment
arm (pooling across centres) (m= 100 imputations).
● Alternative scenarios under ‘Missing Not At Random’27 for poor and
good outcomes: ﬁrst, under a poor outcome assumption, we imputed
missing values in any particular cluster (at baseline or follow-up) using
the largest observed score from that cluster (and time point).
Second, under a good outcome assumption, we used the lowest
observed scores from each cluster (and time point) to impute missing
values.
RESULTS
Baseline characteristics
Thirty-eight general practices (clusters) agreed to participate in the
study, of which 20 were randomised to the intervention arm and
18 to the control arm. Of the patients assessed for eligibility from
the general practice medical records, 1,565 satisﬁed our inclusion
criteria and, of them, 341 agreed to participate (see Figure 1).
Participating (n= 38) and non-participating practices (n= 204)
had comparable demographic characteristics. In Scottish sites, the
mean and s.d. of list size for participating practices was 6,562
(3,363) and that for non-participating practices was 6,971 (3,302)
(P= 0.75); the mean deprivation quintiles were 2.69 (s.d. 0.67) and
2.60 (s.d. 0.70) (P= 0.76), respectively. In English sites, the mean list
size for participating practices was 8,707 (s.d. 4,048) and for non-
participating practices 7,464 (s.d. 4,847) (P= 0.19); the Index of
Multiple Deprivation scores were 26.8 (s.d. 18.2) and 31.0 (s.d. 19.6)
(P= 0.27), respectively.
Clusters were comparable for baseline characteristics in terms of
deprivation; however, the intervention practices had a larger
mean list size (see Table 1). Participants were comparable at
baseline in terms of age and sex proﬁles.
Primary outcome: impact on seasonal allergic rhinitis quality of life
A total of 246/341 patients (50·2% male, mean age 15 years) were
included in the primary outcome analysis. The intervention
failed to result in a clinically important improvement in RQLQ(S)
(−0.15, 95% conﬁdence interval (CI), − 0.52 to +0.21) (adjusted
for baseline RQLQ(S)), practice list size and region, year of study
and deprivation.29
Secondary outcomes
Assessment of change in clinical practice. Health-care profes-
sionals’ self-assessment of their conﬁdence and understanding of
seasonal allergic rhinitis management markedly increased post
intervention when compared with the baseline assessment (see
Table 2). All scores improved from Time 1 (immediately before the
training day) to both Time 2 (immediately after the training day)
and Time 3 (after all patients had been seen as part of the study).
Consultation and prescribing data. Five of the 38 practices did not
provide data on consultation and prescribing patterns (three
control and two intervention arm practices). Table 3 summarises
data revealing that the intervention arm practices tended to have
more consultations and prescriptions in total, and also more
consultations for other respiratory conditions, but that the ﬁgures
for seasonal allergic rhinitis did not differ greatly between the
two arms.
Grass pollen and symptom score data. Figure 2 indicates that the
grass pollen reached sufﬁciently high counts (50–149 pg/m3) at
both sites in both years to induce seasonal allergic rhinitis
symptoms and that there was no signiﬁcant regional variation
between the two collection sites. Adjusted symptom scores in the
intervention group were slightly lower than in the control group
(−0.24, 95% CI, − 1.03 to +0.54).
Estimates of ICC
The ICC was estimated as 0.034 after adjusting for baseline RQLQ
and the intervention group, with a 95% credible interval of
0.0016–0.145.
Sensitivity analysis for impact on quality of life
By using the direct likelihood method28 to account for the missing
data under a Missing At Random mechanism, the (adjusted) effect
of the novel intervention on RQLQ(S) at 6 weeks was found to be
Seasonal allergic rhinitis training workshop
VS Hammersley et al
3
© 2014 Primary Care Respiratory Society UK/Macmillan Publishers Limited npj Primary Care Respiratory Medicine (2014) 14012
0.03 (95% CI, − 0.33 to 0.39), supporting the ﬁnding that there is
no beneﬁcial effect of the intervention on RQLQ(S) score.
We obtained similar results with multiple imputation methods
based on 100 imputed data sets. Using multiple imputations to
account for the missing data, the intervention effect was 0.06
(95% CI, − 0.30 to 0.42).
Finally, under the poor outcomes scenario, imputing missing
data using large RQLQ(S) values, the estimated effect of the
intervention was 0.21 (95% CI, − 0.21 to 0.63). Under the good
outcomes scenario, using low RQLQ(S) values to impute the
missing data, the estimated intervention effect was 0.03 (95% CI,
− 0.39 to 0.44). The conclusions were thus unchanged: the
intervention failed to have the desired effect.
DISCUSSION
Main ﬁndings
This large general practice–based cluster randomised controlled
trial has shown that a short intensive evidence-based allergy
workshop for health-care professionals led to substantial and
persistent improvements in their self-reported conﬁdence and
understanding of the management of seasonal allergic rhinitis, but
this did not translate into changes in clinical practice in terms of
frequency of consultations or prescribing habits; most importantly,
this did not lead to clinically signiﬁcant improvements in disease-
speciﬁc quality of life or symptom score in adolescents with
seasonal allergic rhinitis.
Strengths and limitations of this study
The main strength of this trial was the decision formally to evaluate
this evidence-based educational intervention using an adequately
powered cluster randomised controlled trial, which is most
Table 1. Baseline information for each group at individual and cluster
level
Intervention arm Control arm
Practice factors
Number of clusters 20 18
Mean list size 11,144 8,330
Mean deprivation score
IMDa 21.5 21.7
SIMDb 2.48 2.47
Patient factors
Number 223 118
Mean age (years) (s.d.) 15 (1.85) 15 (1.91)
Number (%) male 112 (50.2) 57 (48.3)
aIMD—The 2004 Index of Multiple Deprivation for English practices.
bSIMD—Scottish Index of Multiple Deprivation.
Invited to participate (n= 242)
Excluded  
Declined to participate (n= 204)
Clusters:
Analysed n= 19
Excluded from analysis n= 63 (did not 
complete quality of life questionnaire)
Participants included in analysis n= 160
Lost to follow-up
0 clusters
63 (23%) participants did not respond to 
quality of life questionnaire
Allocated to intervention n= 20
Received allocated intervention 
19 Clusters, median cluster size = 10, range 
2–40, 223 participants
Did not receive allocated intervention: 
n= 1
Not able to attend educational intervention 
Lost to follow-up
0 clusters
32 (27%) participants did not respond to
quality of life questionnaire
Allocated to control n= 18
Received allocated intervention 
18 Clusters, median cluster size = 7,
range 1–12, 118 participants
Did not receive allocated
intervention: 
Clusters
Analysed n= 18
Excluded from analysis n= 32 (did not 
complete quality of life questionnaire)
Participants included in analysis
n= 86
Allocation
Analysis
Follow-up
Randomised (n= 38)
Enrolment
Figure 1. Flow of clusters and patients through the trial.
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uncommon. We developed a complex intervention based on a
previous effective educational intervention for health-care profes-
sionals and measured the effectiveness of this on a validated
disease-speciﬁc quality of life measure; in keeping with the Medical
Research Council’s complex intervention framework,16 we also
measured a range of relevant process measures, which aimed to
shed light on the mechanisms through which any changes were
mediated and/or blocked. We have demonstrated the acceptability
of the intervention and that it has an impact on professionals’ self-
assessed conﬁdence and knowledge of seasonal allergic rhinitis
management, but that the intervention did not equip individuals
with the ability to enact relevant structural changes in their
practices to translate this into improvements in care processes.
We conducted a complete case analysis supplemented by
sensitivity analyses to assess the likely impact of the missing data.
Our sensitivity analyses strengthened our ﬁnding of no beneﬁcial
effect of the intervention on RQLQ(S). A limitation of this study
may be that patients in the control arm of the cluster trial also
consulted with a health-care professional, which it could be
argued may not reﬂect routine primary care. It was necessary to
design the study this way in order to understand the cause of any
potential effectiveness of the educational intervention and to be
able to distinguish this from any impact of simply being seen for
seasonal allergic rhinitis. Control arm practices received an
algorithm and information leaﬂet for the management of seasonal
allergic rhinitis, both of which were adapted by Education for
Health. One way of disentangling this issue would have been to
include a third arm in which practices received no intervention;
however, this was not possible within the constraints of this trial.
An additional possible limitation of this study is that cluster sizes
were not balanced. We used general practice list size in the
minimisation scheme; we may, however, have reached a better
balance in clusters if we had used number of adolescents, as this
varied between clusters more than we had anticipated. The effect
of this imbalance on the power of the study was small, and we still
achieved the power required.
Table 2. Audit of conﬁdence in delivering allergy care (n= 21)
Question Time 1a Time 2a Time 3a 95% CIb
How conﬁdent are you at
Taking a comprehensive
allergy history from a
patient with suspected
allergy?
2.6 4.2 4.4 1.0, 2.2
Doing skin prick testing? 1.1 2.7 2.4 0.4, 2.6
Ordering speciﬁc IgE test? 1.5 3.8 3.5 1.2, 2.8
Making a diagnosis of
allergy?
2.1 4.4 4.3 1.6, 2.7
Explaining the various
effective treatment
strategies for allergic
problems?
2.2 4.3 4.7 1.9, 2.9
Prescribing/recommending
treatment for allergic
conditions?
2.3 4.1 4.6 1.4, 2.8
Teaching patients how to
use nasal spray devices?
2.3 4.7 5.0 1.9, 3.2
Explaining the causes and
mechanisms of allergy?
2.4 4.2 4.5 1.4, 2.7
Understanding the impact
of allergy on morbidity and
mortality?
2.6 4.2 4.5 1.4, 2.7
How likely are you to do the following
Ask about other allergic
symptoms (e.g., nose/skin)
when assessing a patient
with asthma?
3.3 4.8 4.8 0.6, 2.0
Consider total steroid use in
patients on multiple
therapies?
2.6 4.2 4.1 1.0, 2.2
Offer practical advice on
avoiding allergens?
3.1 4.8 4.9 1.0, 2.4
Suggest patients use their
nasal steroids regularly?
3.1 4.9 5.0 1.3, 2.5
Abbreviation: CI, conﬁdence interval.
aTime 1—immediately before the training day, Time 2—immediately after
the training day, Time 3—after all patients had been seen as part of the
study (range 7–28 days).
b95% CI for change in mean score from Time 1 to Time 3.
Table 3. Consultation and prescribing data
Intervention
arm, n=193
Control arm,
n=88
95% CI a
Total (and mean per
patient) number of
consultationsb
200 (1.04) 85 (0.97) − 0.02, +0.63
Total (and mean per
patient) number of
rhinitis consultationsb
55 (0.28) 29 (0.33) − 0.24, +0.08
Total (and mean per
patient) number of
consultations for other
respiratory conditionsb
27 (0.14) 8 (0.09) − 0.01, +0.22
Total (and mean per
patient) number of
prescriptionsb
557 (2.89) 197 (2.24) +0.08, +2.15
Total (and mean per
patient) number of
prescriptions for rhinitisb
406 (2.10) 140 (1.59) − 0.10, +0.12
Abbreviation: CI, conﬁdence interval.
a95% CI for difference in mean between intervention and control groups.
bCumulative total for all patients from the date they were seen for the trial
consultation to 31 August 2009 or 2010.
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Interpretation of ﬁndings in relation to previously published work
Patients in this study had on average relatively mild impairment of
quality of life measured by the RQLQ(S), which is in line with a
similar study exploring the quality of life of perennial rhinitis
sufferers.14 Patients were recruited from a primary care setting,
using a clinician diagnosis of seasonal allergic rhinitis or a
prescription for drugs used in nasal allergy in the last 2 years,
rather than objective evidence of moderate or severe disease. As
also observed in our earlier perennial rhinitis trial,14 the impact of
this training intervention may have been more evident if we had
restricted trial entry to those with more severe disease. This would,
however, have reduced the generalisability of the intervention to
everyday general practice.
We would have expected more consultations in the interven-
tion group if the training had achieved a sustained change in
clinical practice, but this was not the case. The training days were
delivered by practising health-care professionals and based on
current evidence-based guidelines for the management of
seasonal allergic rhinitis developed by the British Society of
Allergy & Clinical Immunology.19 The prescribing data included all
repeat prescriptions; therefore, if the intervention practices
followed the guidance given in the workshop, patients with
persistent symptoms would be receiving an antihistamine, nasal
steroid and/or topical ocular treatments, as appropriate.
Implications for future research, policy and practice
Future trials need to build on the ﬁndings of both this and our
earlier trial,14 and ﬁnd ways of equipping participants of such
short courses with the skills necessary to bridge the gap between
knowledge and day-to-day practice. A key consideration is not
only to upskill primary care–based health-care professionals but
also to develop their ability to effect organisational change. The
increasing opportunities for blended learning—i.e., a combination
of both face-to-face and virtual training—should also provide
opportunities for periodic, convenient and accessible reinforce-
ment of key messages. Developing such initiatives and then
formally trialling their effectiveness is important to help ensure
that the National Health Service and other health-care systems
internationally invest their limited resources in evidence-based
educational interventions of proven effectiveness.
Conclusions
In conclusion, this intensive seasonal allergic rhinitis training
workshop for primary care health-care professionals was found
acceptable and increased self-assessed conﬁdence in attendees,
but this did not translate into improvements in symptom control
or quality of life of adolescents with seasonal allergic rhinitis.
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